{
    "2021-11-23": [
        [
            {
                "time": "2021-09",
                "original_text": "康泰生物：公司自主研发的13价肺炎球菌多糖结合疫苗为全球首创的双载体13价肺炎球菌多糖结合疫苗，于2021年9月获得药品注册证书",
                "features": {
                    "keywords": [
                        "13价肺炎球菌多糖结合疫苗",
                        "全球首创",
                        "药品注册证书"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-10",
                "original_text": "康泰生物：2021年10月首次获得批签发证明，标志着13价肺炎球菌多糖结合疫苗可在国内外上市销售",
                "features": {
                    "keywords": [
                        "13价肺炎球菌多糖结合疫苗",
                        "批签发证明",
                        "上市销售"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06",
                "original_text": "康泰生物：新冠灭活疫苗III期临床试验6月下旬在海外进行第一针接种，目前在实施中",
                "features": {
                    "keywords": [
                        "新冠灭活疫苗",
                        "III期临床试验",
                        "海外接种"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-present",
                "original_text": "康泰生物：公司的腺病毒载体新冠疫苗近期已获得印度尼西亚国家药品和食品监管局紧急使用授权",
                "features": {
                    "keywords": [
                        "腺病毒载体新冠疫苗",
                        "紧急使用授权",
                        "印度尼西亚"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-present",
                "original_text": "康泰生物：冻干水痘减毒活疫苗已完成Ⅲ期临床研究现场工作",
                "features": {
                    "keywords": [
                        "冻干水痘减毒活疫苗",
                        "Ⅲ期临床研究",
                        "完成"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-present",
                "original_text": "康泰生物：变异株的疫苗研发目前处于临床前研究阶段",
                "features": {
                    "keywords": [
                        "变异株疫苗",
                        "临床前研究",
                        "研发"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-present",
                "original_text": "康泰生物：公司在开展3-17岁人群的临床现场",
                "features": {
                    "keywords": [
                        "3-17岁人群",
                        "临床现场",
                        "开展"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-present",
                "original_text": "康泰生物：冻干人用狂犬病疫苗（人二倍体细胞）生产注册申请已获得国家药品监督管理受理",
                "features": {
                    "keywords": [
                        "冻干人用狂犬病疫苗",
                        "生产注册申请",
                        "受理"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}